Polychlorinated biphenyls (PCBs) are persistent organic pollutants that remain a human health concern with the discovery of new sources of contamination and ongoing bioaccumulation and biomagnification. Children exposed during early brain development are at highest risk of neurological deficits, but there is some evidence that high PCB exposure in adults increases the risk of Parkinson's disease. Our previous studies found allelic differences in the aryl hydrocarbon receptor and cytochrome P450 1A2 (CYP1A2) affect susceptibility to developmental PCB exposure, resulting in cognitive deficits and motor dysfunction. High-affinity Ahr b Cyp1a2(-/-) mice were most susceptible compared with poor-affinity Ahr d Cyp1a2(-/-) and wild type Ahr b Cyp1a2(+/+) mice. Our follow-up studies assessed biochemical, histological and gene expression changes to identify the brain regions and pathways affected. We also measured PCB and metabolite levels in multiple tissues to determine if genotype altered toxicokinetics. We found evidence of AHR-mediated immune suppression with reduced thymus and spleen weights and significantly reduced thyroxine at P14. In the brain, the greatest changes were seen in the cerebellum where a foliation defect was over-represented in Cyp1a2(-/-) mice. In contrast, we found no difference in tyrosine hydroxylase immuno-staining in the striatum. Gene expression patterns varied across the three genotypes, but there was clear evidence of AHR activation. Distribution of parent PCB congeners also varied by genotype with strikingly high levels of PCB 77 in poor-affinity Ahr d Cyp1a2(-/-) while Ahr b Cyp1a2(+/+) mice effectively sequestered coplanar PCBs in the liver. Together, our data suggest that the AHR pathway plays a role in developmental PCB neurotoxicity, but we found little evidence that developmental exposure is a risk factor for Parkinson's disease.
Introduction
Polychlorinated biphenyls are persistent organic pollutants linked to numerous adverse health effects in humans, including immune suppression, endocrine disruption, and neurological deficits (ATSDR 2015) . Despite numerous bans on commercial production, PCBs remain ubiquitous in the environment and the food supply (Gomara et al. 2005; Langer et al. 2007; Malisch and Kotz 2014; Marek et al. 2017) . New PCB sources have recently been identified, including their inadvertent production during the manufacture of paint pigments (Hu & Hornbuckle 2010) and the discovery of PCBs in and around many U.S. schools (Marek et al. 2017) . Because PCBs are lipophilic and can bioaccumulate and biomagnify, the risk to pregnant women and their offspring is expected to remain high for years to come (Quinn et al. 2011; Bányiová et al. 2017 ).
The evidence for PCB-induced motor dysfunction comes from both human and animal studies. Stewart et al. (2000) , Vreugdenhil et al. (2002), and Boucher et al. (2016) all reported motor deficits in children exposed to high levels of PCBs. Hydroxylated PCB metabolites are also linked with motor dysfunction (Berghuis et al. 2013; Haijima et al. 2017) . Steenland et al. (2006) reported a higher risk of Parkinson's disease (PD) in women with high occupational exposure. Similarly, Petersen et al. (2008) reported a higher risk of PD in adults with high consumption of contaminated whale meat and blubber. The risk of PD is consistent with animal studies showing dopamine depletion after PCB exposure (Seegal et al. 1994 (Seegal et al. , 1997 (Seegal et al. , 2005 .
However, PCBs are a diverse group of chemicals with 209 possible congeners and multiple targets in the body. PCBs are well known to deplete thyroid hormone levels (Curran et al. 2011a; Giera et al. 2011) , and supplemental thyroxine rescues PCB-induced motor deficits (Goldey and Crofton 1998) . Interestingly, CYP1A1 can metabolize some PCB congeners into hydroxylated metabolites that disrupt thyroid hormone signaling (Gauger et al. 2007; Wadzinski et al. 2014) . Since thyroid hormone is essential for normal cerebellar development (Zoeller and Rovett 2004) , it is possible that at least some of the observed motor deficits could be caused by cerebellar dysfunction and not deficits in the nigrostriatal pathways affected in Parkinson's disease.
Our previous work demonstrated that allelic differences in the aryl hydrocarbon receptor (AHR) and cytochrome P450 1A2 (CYP1A2) alter susceptibility to developmental PCB neurotoxicity, leading to greater impairments in learning and memory (Curran et al. 2011b (Curran et al. , 2012 and impaired motor function in Ahr b Cyp1a2(-/-) knockout mice (Stegman et al. 2014; Colter et al. 2017 submitted) . Both of these genes are highly polymorphic in the human population ), so our model mimics human genetic variation. The focus of this project was to further characterize genetic susceptibility to PCBs and to explore mechanisms of neurotoxicity by examining changes in thyroid hormone signaling and gene expression in brain regions required for normal motor function: the dorsal striatum, cerebellum and cortex.
Materials and Methods
Animals. We used C57BL/6J mice (The Jackson Laboratory, Bar Harbor ME) with the Ahr b Cyp1a2(+/+) genotype and two lines of knockout mice which have been back-crossed at least 8 generations onto the B6 background: high-affinity Ahr b Cyp1a2(-/-) and poor-affinity Ahr d Cyp1a2(-/-) mice. All mice were housed in polysulfone shoebox cages with corncob bedding and one 5 cm 2 nestlet provided weekly for enrichment. Food (LabDiet 5015) and water were provided ad libitum with a 12h:12h light dark cycle under temperature and humidity-controlled conditions. A maximum of one male and one female per litter was used in each test (N ≥ 6 litters per group for all tests).
Breeding. Nulliparous females between 2.5 and 4 months of age were mated with males of the same genotype in a 4-day breeding cycle. The morning a vaginal plug was found, the female was separated from the male and housed individually for delivery.
Treatments. An environmentally relevant mixture of PCBs (coplanar PCBs 77, 126, 169 and noncoplanar PCBs 105, 118, 138, 153 and 180, ULTRA Scientific, North Kingstown RI) were dissolved in corn oil, and dams were dosed daily by providing a small piece of Froot Loop® cereal containing the PCB solution or plain corn oil for control animals. Additional information regarding the dosing solutions is provided as Supplemental Material (Table S1 ). Dosing began the afternoon of the day a vaginal plug was found and continued through postnatal day 25 (P25) with animals randomly assigned to each group.
Tissues. To avoid confounding by circadian rhythms, all tissues were collected during the same 3h time period (15:00-18:00h) at P14, P25, P30 and P120. Blood was collected by cardiac puncture for PCB quantification. Trunk blood was collected for thyroid hormone measurements, centrifuged at 1500G for 5 min at 4°C, and the plasma fraction stored at -80°C until analysis. Liver, inguinal fat pad, cerebellum, and cortex were harvested, snap frozen and stored at -80°C until analysis. Spleen and thymus were dissected out in P14 mice and wet weights recorded.
Thyroid hormone measurements. Total thyroxine (T4) levels were measured using a standard ELISA kit (Alpco Diagnostics, Salem NH) following the manufacturer's protocol. We measured T4 levels at P14 and in P120 littermates used in motor function tests.
Tissue processing for immunohistochemistry. Mice were euthanized with CO2 and perfused transcardially with 1X PBS followed by 4% paraformaldehyde in phosphate buffer. Brains were removed and cryoprotected in 30% sucrose in 0.1 M PBS for coronal sectioning on a cryostat (striatum) or sagittal sectioning on a vibratome (cerebellum). Brains were collected at P25 and at P120 from littermates used for motor function testing.
Immunohistochemistry for tyrosine hydroxylase in striatum. Six striatal sections per animal were selected for immunohistochemistry. To enhance antigen retrieval, we soaked tissue in sodium citrate buffer at 80° C for 30 min followed by washes in 0.1 M PBS. Next, tissues were incubated in 0.3% H2O2 (Sigma) in 0.1M PBS for 30 min at room temperature with shaking. The solution was replaced with normal goat serum/Triton 100X blocking solution and incubated for 2 h at room temperature with shaking. The tissue was then incubated in the primary antibody (Abcam Cat# ab112, RRID:AB_297840) at a 1:5000 dilution in blocking solution at 4° C for 48 h with shaking. After washes to remove the primary antibody, the slices were incubated for 2 h in the secondary antibody (anti-rabbit IgG biotinylated antibody from Vector ABC Elite kit) at room temperature with shaking. The slices were then incubated in HRP-ABC complex (Vector ABC Elite) for 1 h at room temperature with shaking followed by staining with diaminobenzidine (Vector DAB kit) and incubation for 10 min at room temperature. Following a final 15-min rinse sequence with 0.1M PBS, the sections were stored in 0.1M PBS with 0.05% sodium azide until mounting.
Optical density analysis. Slides were viewed on an Olympus microscope with a Motic Camera attachment at 10X magnification and associated software (Version 2.0). Slides were photographed in grayscale for importing into ImageJ. All images were calibrated using the standard ImageJ step tablet to ensure uniformity. Background was subtracted using the rolling ball radius function. A grid was overlaid on the image and the line closest to the center of the striatum as possible was selected. This area was divided evenly into left and right dorsal and ventral quadrants. We used a random number generator to select six squares from each hemisphere for analysis ( Fig. 1) . The optical density of each square was measured, and the mean O.D. for each hemisphere was calculated for statistical analysis following the methods of (González- Franco et al. 2017 ).
Immunohistochemistry and image analysis of cerebellum. Vibratome floating sections were blocked in PBS 1X/Triton 100X 0.3%/FBS and processed for immunodetection of proteins using specific antibodies for GFAP (Sigma-Aldrich; G-3893), Blbp (Millipore; ABN14) Parvalbumin (Millipore; AB15738), Calbindin (Sigma-Aldrich; C8666), and NeuN (Millipore; MAB377). The appropriate fluorophore-conjugated secondary antibodies (Alexa 488, Alexa 568, Alexa 647; Invitrogen) were used to detect the antigen-antibody complexes. Nuclei were stained with DAPI, and sections were mounted on slides using Fluoromount G (Thermo Fisher). Using the appropriate laser excitation wavelength (405, 488 or 561 nm), images were captured on a Nikon C2 confocal microscope. ImageJ (NIH) software was used to calculate the perimeter and area of the granule cell layer and to compare the number of Purkinje cells across different folia. Images were assessed by investigators blinded to genotype and treatment groups.
Real-time quantitative PCR arrays. Tissues were homogenized in RNAzol (Molecular Research Center, Cincinnati, OH) with 50-100 mg tissue per ml RNAzol using a Dounce homogenizer for cortex and cerebellum and a Polytron-type homogenizer for liver. RNA was extracted using the manufacturer's protocol, and the RNA pellets were re-suspended in 50 µl of nuclease-free water for brain and in 75 µl for liver. RNA concentration was quantified on a Nanodrop (Thermo Fisher), and 500 ng total RNA was used for the cDNA reaction using the RT 2 First Strand Kit (Qiagen).
The cDNA was analyzed using an RT 2 Custom PCR Array (Qiagen) with primers for 39 candidate genes, 5 housekeeping genes, and negative and positive controls. Genes were selected after a literature search for genes related to activation of the aryl hydrocarbon receptor, cerebellar development, oxidative stress, neuroinflammation, and other pathways implicated in PCB toxicity and endocrine disruption (ryanodine receptor/calcium homeostasis, estrogen and thyroid hormone pathways). Two samples were run on each 96-well plate in an Applied Biosystems 7300 Real-time PCR system using the following program: 10 min at 95°C, 40 cycles of 15 s at 95°C followed by 1 min at 60°C. The RT 2 PCR Array Data Analysis version 3.5 was utilized to compare fold-change in three genotypes of PCB-treated mice with corn oil-treated wild-type mice using the Delta-Delta Ct method.
Chemicals for PCB quantification. Analytical standards of 2,3,5,6-tetrachlorobiphenyl (PCB 65, 99.4%); 2,3,3′,4,4′-pentachlorobiphenyl (PCB 105, > 99.9%); 2,2′,3,4,4′,5′-hexachlorobiphenyl (PCB 138, > 99.9%); 2,3,4,4′,5,6-hexachlorobiphenyl (PCB 166, 99%); 3,3′,4,4′,5,5′hexachlorobiphenyl (PCB 169, 99%); 2,2′,3,4,4′,5,5′-heptachlorobiphenyl (PCB 180, 99.2%), 2,2′,3,4,4′,5,6,6′-octachlorobiphenyl (PCB 204, 99.9%) and 2′,3,3′,4′,5,5′-hexachlorobiphenyl-4ol (4-159, > 99.9%) were purchased from AccuStandard (New Haven, CT). Standards of 3,3′,4,4′tetrachlorobiphenyl (PCB 77); 2,3′,4,4′,5-pentachlorobiphenyl (PCB 118); 3,3′,4,4′,5pentachlorobiphenyl (PCB 126) and 2,2′,4,4′,5,5′-hexachlorobiphenyl (PCB 153) were synthesized as described previously (Kania-Korwel et al. 2004 , Lehmler and Robertson 2001 , Schramm et al. 1985 . Methylated standards of OH-PCBs, including 2,3,3′,4′,5-pentachloro-4methoxybiphenyl (4-107, >98%); 2,2′,3′,4,4′5-hexachloro-3-methoxybiphenyl (3′-138, >98%); 2,2′,3,4′,5,5′-hexachloro-4-methoxybiphenyl (4-146, >98%) and 2,2′,3,4′,5,5′,6-heptachloro-4methoxybiphenyl (4-187, >98%), were purchased from Wellington Laboratories (Guelph, ON), Canada. Hydroxylated metabolite standards of PCB 77, including 3,3′,4′,5-tetrachloro-biphenyl-4-ol (4′-79); 3′,4,4′,5-tetrachlorobiphenyl-3-ol (5-77); and 3′,4,4′,5-tetrachlorobiphenyl-2-ol (6-77) were prepared as described previously (van den Hurk et al. 2002) . Standards synthesized in our laboratory were >99% pure by GC analysis. The nomenclature of metabolites follows an abbreviated nomenclature proposed by Maervoet et al. (2004) .
Extraction of tissues. Adipose (0.0606 -0.3107 g), blood (0.2446 -0.5884 g), cerebellum (0.0319 -0.0573 g), cortex (0.1215 -0.2468 g) and liver samples (0.2402 -0.2468 g) were spiked with surrogate standards (PCBs 65 and 166, 4-159) and extracted with hexane-acetone (1:1 v/v) using an Accelerated Solvent Extractor (Dionex, Sunnyvale, CA) as described previously (Kania-Korwel et al. 2007 ). Sample blanks containing only Florisil and diatomaceous earth as well as an ongoing precision and recovery (OPR) standard (i.e, sample blanks spiked with all analytes) were extracted in parallel with each set of samples. Extracts were concentrated and derivatized with diazomethane to transform OH-PCBs into methoxylated compounds for gas chromatographic analysis (Kania-Korwel et al. 2008) . Afterwards, samples underwent sulfur clean-up, followed by sulfuric acid treatment as reported previously (Kania-Korwel et al. 2005) .
Gas chromatography analysis.
Levels of PCBs and OH-PCB metabolites in each extract were quantified using an Agilent 6890N or Agilent 7890A gas chromatograph equipped with a SPB-1 column 60 m length, 0.25 mm inner diameter, 0.25 µm film thickness; Supelco, St. Louis, MO) and a 63 Ni µ-electron capture detector. The injector and detector temperatures were 280°C and 300°C, respectively. The following temperature program was used: 80°C for 1 min, 15°C/min increase to 260°C, 1°C/min increase to 274°C, 15°C/min increase to 300°C. PCBs 105+153 and 5-77+4-107 co-eluted on the SPB-1 column and are reported as sum of both co-eluting compounds. PCB and OH-PCB levels were calculated using PCB 204 as volume corrector and adjusted for tissue wet weights. The instrument and method detection limits for target analytes are summarized in Table S2 .
Quality assurance/quality control. The detector response was linear (R 2 > 0.99) in the range from 1 to 500 ng for all analytes (R 2 > 0.99). The recoveries of the surrogate standards PCB 65, PCB 166 and 4-159 were 88±11% (range: 53-112), 94±13% (range: 55 to 129) and 80±18% (range: 29 to 114), respectively. The concentrations of target analytes were corrected by the recoveries of the surrogate standards added to each sample. The recoveries from the OPR standard analyzed in parallel with each sample set ranged from 78 to 112%.
Statistical analysis
Data were analyzed using SAS Proc Mixed Models Analysis of Variance with litter as the unit of analysis. When differences were found, we examined slice effects with a correction for multiple post-hoc analyses. For statistical analyses of PCB congeners and metabolites, values were set to the Limit of Detection for samples shown as Not Detected (ND). To compare the frequency of the cerebellar foliation deficit, we used a Chi Square analysis. Data are presented as least square means ± the standard error of the mean (SEM). For all analyses P < 0.05 was considered significant.
Results

Evidence of immune suppression.
There was a main effect of PCB treatment and a significant gene x treatment interaction with PCB-treated P14 pups having significantly lower spleen (P < 0.01) and thymus (P < 0.001) wet weights. The greatest immune suppression was seen in PCBtreated
Thyroid hormone levels. Total plasma thyroxine (T4) was significantly lower at P14 in all three genotypes of mice exposed to PCBs during gestation and lactation (P < 0.001); however, T4 levels returned to normal in adult mice where there were no significant differences (Figs. 3A-C).
Optical density measurements of striatum. We compared tyrosine hydroxylase staining in the striatum of PCB-treated mice from all three genotypes to values from corn oil-treated control B6 mice. There were no significant differences in tyrosine hydroxylase staining across these four groups (Fig. 4) .
Histology of cerebellum.
Decreases levels of thyroxine in PCB-treated mice (Figs. 3A-C) may affect biological processes where thyroid hormone is requested, such as cerebellum development.
To test this possibility, we analyzed cerebellar structure and cellular composition in vehicle-and PCB-treated mice. We found no significant differences in the total area of the cerebellum at the level of the vermis, the area of the granule cell layer, the number of Purkinje cells, or the perimeter of the Purkinje cell layer in PCB-treated mice compared with their respective corn oil-treated controls (data not shown).
Cerebellar foliation defect.
A comparison of sagittal sections from control B6 mice and PCBtreated knockout mice revealed a foliation defect involving folia VIII and IX (Figs. 5A-B ). This observation was followed up with a detailed analysis of cerebellar sections from all groups. We observed abnormal foliation patterns at a significantly higher frequency in PCB-treated mice (P < 0.01) with the highest percentage (67%) in PCB-treated Ahr b Cyp1a2(-/-) mice followed by 50% of PCB-treated Ahr d Cyp1a2(-/-) mice. In contrast, only 18% of corn oil-treated control mice showed the defect. In addition to aberrant lamination, we also detected invasion of Bergmann glial cells into the granule cell layer of PCB-treated knockout mice (Figs. 6A-F). These results suggest late cerebellar developmental defects in response to PCBs. Gene expression differences in cerebellum and cortex. Based on the histology and immunohistochemistry results, we focused our gene expression studies on the cerebellum and the cortex, because both play a role in regulating motor function and motor memory. All changes in gene expression were compared with corn oil-treated control mice of the Ahr b Cyp1a2(+/+) genotype (i.e. the C57BL/6J strain). Details of fold-changes and P-values can be found in Tables 1-3.
Differences at P14 in cerebellum. We found only three significant differences in PCB-treated Ahr b Cyp1a2(+/+). Expression of the aryl hydrocarbon receptor and fibroblast growth factor-2 were modestly upregulated whereas expression of estrogen receptor alpha was more than doubled. Only Ahr b Cyp1a2(-/-) mice showed clear evidence of AHR activation with increases in both the aryl hydrocarbon receptor (1.88 fold increase) and CYP1A1 (2.01 increase), although the increase in CYP1A1 was not statistically significant. There was a significant down-regulation of retinoidrelated orphan receptor-alpha (Rorα), neurotrophin-3 and glutamate-cysteine ligase modifier (Gclm). Gene expression in poor-affinity Ahr d Cyp1a2(-/-) mice had some similarities to wild type mice with significant increases in fibroblast growth factor-2 and estrogen receptor alpha. There were also significant increases in insulin-like growth factor-1 and ryanodine receptor-3. The greatest change was a more than 6-fold decrease in expression of Purkinje cell protein-2 (Pcp2); however the differences did not reach statistical significance (P = 0.09).
Differences at P30 in cerebellum.
Unexpectedly, all three lines of mice showed evidence of AHR activation in the cerebellum at P30, but the patterns of gene expression differed based on Cyp1a2 genotype. CYP1B1 was significantly upregulated in Ahr b Cyp1a2(+/+) mice, whereas the AHR was down-regulated and CYP1A1 was upregulated in both Ahr b Cyp1a2(-/-) and Ahr d Cyp1a2(-/-) mice. We also found some evidence of compensatory processes with upregulation of both NMDA receptor subtype-2A (Grin2a) and nerve growth factor only in wild type Ahr b Cyp1a2(+/+) mice, but the differences did not reach statistical significance (P = 0.06 and P=0.09 respectively).
Differences at P14 in cortex.
The pattern of gene expression in cortex was much different. Nerve growth factor was significantly down-regulated in high-affinity Ahr b Cyp1a2(+/+) and pooraffinity Ahr d Cyp1a2(-/-) mice. Similar to P14, estrogen receptor alpha was also significantly upregulated in Ahr d Cyp1a2(-/-) mice. The most pronounced differences were in high-affinity Ahr b Cyp1a2(-/-) mice with clear evidence of AHR activation by significant upregulation of both CYP1A1 and CYP1B1. There was also significant down-regulation of myelin basic protein, Grin2a, prostagland G/H synthase-2 (Ptgs2) and paraoxonase-2 (Pon2).
Tissue levels of PCB and hydroxylated metabolites.
To determine if differential toxicokinetics could partially explain differences in gene expression, we compared levels of the parent PCB congeners in cerebellum, cortex, liver, adipose and blood (Table 4 ) and hydroxylated metabolites in blood and liver (Table 5 ). We found strikingly high levels of coplanar PCB 77 in adipose, liver, and blood of poor-affinity Ahr d Cyp1a2(-/-) mice and also significantly higher levels in cerebellum with no difference in cortex. Levels of coplanar PCB 126 were significantly higher in the liver of high-affinity Ahr b Cyp1a2(+/+) mice. Levels of coplanar PCB 169 were also higher in this line, although the differences didn't reach statistical significance. In contrast, PCB 126 levels were significantly higher in the blood and adipose of the two Cyp1a2(-/-) knockout lines of mice.
When comparing levels of noncoplanar PCB congeners, we found significantly higher levels of PCB105+PCB153 in the blood and cerebellum of Ahr b Cyp1a2(-/-) mice and significantly higher levels in the liver and adipose of both Cyp1a2(-/-) knockout lines. Levels of PCB 118 were significantly higher in the cerebellum of Ahr b Cyp1a2(-/-) mice and significantly higher in the blood of both Cyp1a2(-/-) knockout lines. Levels of PCB 138 were significantly higher in the cerebellum of Ahr b Cyp1a2(-/-) mice with no significant differences in other tissues. Levels of PCB 180 were significantly higher in the cerebellum, blood and liver of Ahr b Cyp1a2(-/-) mice with no differences in cortex and adipose.
Discussion
Although the neurotoxicity of PCBs has been well established (Jacobson et al. 1997; Jacobson et al. 2003; Schantz et al. 2003; Ross 2004) , less is known about the cause of motor deficits following PCB exposure, and there is minimal data concerning genetic susceptibility to PCBs. Of specific concern to human health is the possibility that PCBs may be a risk factor for Parkinson's disease (Steenland et al. 2006; Caudle et al. 2008 ) and reports of motor deficits in children exposed to high levels during early brain development (Stewart et al. 2000; Vreugdenhil et al. 2002; Wilhelm et al. 2008) . Because human body burdens are expected to remain high for several generations (Quinn et al. 2011 ), understanding genetic susceptibility will be important in identifying and protecting the most vulnerable human populations from PCB-induced motor dysfunction.
Our prior work looking at developmental PCB neurotoxicity in mice revealed that differences in both the aryl hydrocarbon receptor and CYP1A2 affect susceptibility to PCB-induced learning and memory deficits (Curran et al. 2011b (Curran et al. , 2012 . We have now extended those studies to PCB-induced motor dysfunction and found similar genetic differences in susceptibility (Stegman et al. 2014; Colter et al. 2017 submitted) . The studies reported here were designed to identify the specific brain regions affected and the critical pathways involved in motor dysfunction. By assessing multiple endpoints, we were able to address three important questions: What is the evidence that PCBs are a risk factor for Parkinson's disease? Can motor deficits be explained instead by thyroid hormone depletion and cerebellar dyfunction? Is there cross-talk between AHR-mediated pathways and other pathways involved in PCB neurotoxicity?
Immune suppression is a hallmark of AHR-mediated developmental toxicity, which can be easily assessed by measuring spleen and thymus weights in neonates (Lin et al. 2011; Curran et al. 2006 Curran et al. , 2011a . We found strong evidence of immune suppression in the Ahr b Cyp1a2(-/-) mouse line previously identified as most susceptible to PCB-induced neurotoxicity ( Figs. 2A-D) . We also found significant upregulation of AHR target genes in this mouse line in both cerebellum and cortex (Tables 1-3) with more modest changes in AHR-regulated genes in the other lines of mice. Together, these findings support prior studies that maternal CYP1A2 is protective against AHRmediated toxicity (Diliberto et al. 1997; Dragin et al. 2006; Curran et al. 2011a-b) and that highaffinity Ahr b mice are more susceptible than poor-affinity Ahr d mice (Curran et al. 2006 (Curran et al. , 2011a .
We compared thyroid hormone levels at P14 and at 4 months of age (Figs. 3A-C). Our findings were consistent with previous reports showing depletion of circulating thyroid hormone in neonatal mice (Banal and Zoeller 2008; Darras 2008; Curran et al. 2011b ), but we found no difference in T4 levels in adult mice. The greatest depletion in T4 occurred in PCB-treated Ahr b Cyp1a2(-/-) mice, again suggesting this genotype is uniquely susceptible. In addition to previously described changes in AHR-regulated genes, the greatest changes seen in our qPCR arrays were in genes involved in thyroid hormone pathways. PCB-treated Ahr b Cyp1a2(-/-) mice had decreased expression of Rorα, which normally enhances thyroid hormone signaling (Qui et al. 2009 ) and is mutated in the staggerer mouse resulting abnormal cerebellar development (Hamilton et al. 1996) . PCB-treated Ahr b Cyp1a2(-/-) mice also had significantly decreased levels of neurotrophin-3 at P14. Our findings are consistent with thyroid hormone depletion and those of Koibuchi et al. (2001) who reported decreased expression of Ntf-3 and Rorα in hypothyroid neonatal mice.
We also found differences in the expression of Fgf2, Mbp, Ngf, and Pcp2, which are all regulated, at least in part, by thyroid hormone (Koibuchi & Chin 2000) . Interestingly, the direction of change varied across genotypes and brain regions. Upregulation of Fgf2 and estrogen receptor-alpha in wild type Ahr b Cyp1a2(+/+) and poor-affinity AhrdCyp1a2(-/-) mice could indicate some compensatory mechanism in response to PCB exposure while the 6-fold down-regulation of Pcp2 in AhrdCyp1a2(-/-) mice indicates a unique mode of action for PCB toxicity in that line.
Hydroxylated PCB metabolites appear most important in causing abnormal cerebellar development (Giera et al. 2011; Takekuchi et al. 2011; Berghuis et al. 2013) , and there is evidence that CYP1A1 can metabolize non-coplanar PCBs (Gauger et al. 2007 ) altering the expression of thyroid hormone-regulated genes during human fetal development (Wadzinski et al. 2014 ). Koh et al. (2016 recently reported finding hydroxylated PCB metabolites in 60% of human sera samples, so we also examined PCB distribution and metabolism in weanling pups.
We found significant differences across genotypes with poor-affinity AhrdCyp1a2(-/-) mice showing strikingly high levels of coplanar PCB 77 in adipose, liver, and cerebellum. This was consistent with our previous findings in gavage-treated animals (Curran et al. 2011A) . Wild-type Ahr b Cyp1a2(+/+) mice had significantly higher levels of coplanar PCB 126 in liver whereas both Cyp1a2(-/-) lines of mice had higher levels in adipose (Table 4 ). This is also consistent with our previous findings and evidence of coplanar PCB sequestration by maternal CYP1A2. However, there were no significant differences in the production of hydroxylated PCB metabolites (Table  5) . Since our previous work demonstrated differences in parent congener levels throughout gestation and lactation, it will be important to extend these studies to other development time points and to assess both parent congeners and hydroxylated PCB metabolites.
Our histological analysis and immunohistochemistry experiments focused on effects in the cerebellum and striatum to determine which region was most affected by developmental PCB exposure. We found no differences in the area and perimeter of the cerebellum or granule cell layer and no difference in Purkinje cell numbers. However, we discovered a foliation defect between folia VIII and IX that was significantly more prevalent in PCB-treated Cyp1a2(-/-) mice (Figs. 6A-F). This was a novel finding for PCB-treated mice, although the defect has been reported in the background B6 strain previously (Van Dine et al. 2015) . Still, Faquier et al. (2014) clearly identified Begmann glia and Purkinje cells as targets of thyroid hormone receptor-alpha during postnatal cerebellum development. Disruption is normal signaling resulted in abnormal granule cell migration and differentiation. In contrast, we found no differences in tyrosine hydroxylase staining in the striatum indicating no substantial changes in nigrostriatal dopaminergic pathways. Together, these data suggest that the primary target of PCB-induced motor dysfunction is the developing cerebellum and that the mechanism of toxicity is linked to disruptions in normal thyroid hormone signaling. In fact, motor dysfunction has been previously associated with defects in the development of folias VIII-IX of the cerebellum (López-Juárez et al. 2011).
We found no evidence of oxidative stress or neuro-inflammation at the time points tested and no evidence that genes important to calcium homeostasis were changed. There was a significant, but modest 1.27-fold increase in expression of ryanodine receptor-3 in the cerebellum of Ahr d Cyp1a2(-/-) mice at P14. The functional significance of that change is uncertain, but the findings are worth further exploration since the ryanodine receptor is strongly linked to PCB neurotoxicity (Pessah et al. 2010) .
Conclusions.
We conclude that while all mouse lines experienced some level of PCB developmental toxicity, high-affinity Ahr b Cyp1a2(-/-) mice were most susceptible and Ahr b Cyp1a2(+/+) mice were most resistant. AHR activation appears to be a key difference between the two knockout lines with distinct gene expression patterns seen in Ahr b Cyp1a2(-/-) v. Ahr d Cyp1a2(-/-) mice and significant differences in PCB distribution and metabolism as well. We found multiple lines of evidence converging on the cerebellum as the primary target organ for PCB-induced motor deficits with disruption of normal thyroid hormone signaling the most likely mode of action. There was minimal evidence that developmental PCB exposure is a risk factor for Parkinson's disease. However, this does not rule out the possibility of neurotoxicity in adults exposed over a longer period of time or to higher doses from occupational exposures. There was a main effect of treatment with PCB-exposed pups having significantly lower spleen weights at P14 compared to vehicle-treated controls. There was also a significant gene * treatment interaction with PCB-treated Ahr b Cyp1a2(-/-) knockout mice having significantly lower spleen weights than all other groups. ** P < 0.01, *** P < 0.001
Figure Legends
Figs. 2C-D Thymus wet weights.
There was a main effect of treatment with PCB-exposed pups having significantly lower thymus weights at P14 compared to vehicle-treated controls. There was no gene * treatment interaction, although Ahr b Cyp1a2(-/-) knockout mice showed the greatest reduction compared to controls. *** P < 0.001
Figs. 3A-B Thyroxine levels in neonates.
There was a main effect of treatment with PCB-exposed pups having significantly lower circulating free thyroxine at P14 compared to vehicle-treated controls. There was no gene * treatment interaction, although Ahr b Cyp1a2(-/-) knockout mice showed the greatest reduction compared to controls. *** P < 0.001
Figs. 3A-B Thyroxine levels in adults.
Free thyroxine levels returned to normal in adult mice tested at 4 months of age with no significant differences by genotype or treatment. P > 0.05 Purkinje cell protein-2 ↓ 6.37 0.09 Table 4 . Tissue levels of PCBs in three genetically different pup groups. Values are presented as mean ± standard error in ng/g wet weight. * P < 0.05, ** P < 0.01, *** P < 0.001 Table S2 . Linear range and R 2 , instrument and method detection limit for all target analytes in this study.
Tissue Congener Ahr b Cyp1a2(+/+) Ahr b Cyp1a2(-/-) Ahr d Cyp1a2(-/-)
Compounds R 2 (0 -500 ng) Instrument detection limit 1 (ng) 1 Instrument detection limit was determined based on calibration curve as described in (Loconto 2006) ; 2 Method detection limit was determined using mean and standard deviation of target analytes levels in method blanks (samples containing only chemicals used in procedure) as described previously (Kania-Korwel et al. 2007) . Table S3 . Background PCB and OH-PCB levels (ng/g wet weight) in animals exposed to vehicle alone (corn oil).
